Notably, cytotoxic CD8+ T lymphocytes kill tumor cells via the recognition and binding of tumor-associated antigens presented by the class I human leukocyte antigen (HLA-I) alpha chain and beta-2 microglobulin (β2 m). The gene discussed is CD8A; the disease is neoplasm.